Supernus Pharmaceuticals Inc (NAS:SUPN)
$ 36.64 -1.11 (-2.94%) Market Cap: 2.02 Bil Enterprise Value: 1.72 Bil PE Ratio: 34.28 PB Ratio: 2.01 GF Score: 83/100

Supernus Pharmaceuticals Inc (SUPN) Transcripts

  • 1